儿童期多发性硬化患者两年认知功能随访研究
本研究在美国7个中心招募儿童期多发性硬化(MS)患者、年龄匹配的健康儿童及早发型MS成人,随访约2.15年,使用CBB和BICAMS评估认知变化。结果显示两组儿童CBB复合z评分变化无显著差异,但儿童MS组认知下降比例(19.7%)显著高于对照组(5.1%),提示部分患者存在认知 processing speed 下降。
要点
- 儿童MS患者2年内多数认知功能稳定,与健康儿童变化相似。
- 约19.7%的儿童MS患者出现认知下降,高于健康对照的5.1%。
- 临床需关注儿童MS患者认知 processing speed 的纵向变化。
核心结论
- 多数儿童MS患者早期2年内认知功能稳定,纵向变化与健康儿童大体相似。
- 部分儿童MS患者认知 processing speed 较健康儿童下降。
研究设计与样本
- 多中心纵向队列研究,纳入儿童MS、年龄匹配健康儿童及早发型MS成人,随访约2.15年。
- 随访完成率:儿童MS 63/72(87.5%),健康儿童 81/99(81.8%),成人MS 48/66(72.7%)。
主要发现
- 儿童MS与健康儿童CBB复合z评分变化无显著差异(0.10 vs 0.31,p = 0.113)。
- 儿童MS与成人MS的CBB复合z评分变化无显著差异(0.10 vs 0.00,p = 0.987)。
- 基于RCI,儿童MS组认知下降比例19.7%,健康对照组5.1%,差异显著(p = 0.022)。
关键数值与推荐
- 主要结局为CBB复合z评分变化,次要结局包括BICAMS复合z评分及单项z评分变化。
- 采用可靠变化指数(RCI)判定个体水平的有意义变化。
临床怎么用
- 对儿童MS患者应进行纵向认知监测,尤其关注 processing speed 的下降。
- 认知下降并非普遍现象,多数患者短期稳定,需个体化评估。
局限性
- 随访时间仅约2年,长期认知轨迹不明确。
- 部分参与者失访,可能影响结果代表性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Pediatric multiple sclerosis (MS) affects children and adolescents at an important time for neurologic and cognitive development. Although cognitive impairment has been described, few longitudinal studies of cognitive functioning in pediatric MS with matched controls are available. Here, we report the 2-year follow-up cognitive results of a cohort of participants with MS and healthy controls (HCs) recruited from multiple regions of the United States. METHODS: Three cohorts-participants with pediatric MS, age-matched pediatric HC, and adults with early-onset MS-were recruited across 7 sites through the United States Network of Pediatric MS Centers. Two cognitive batteries, Cogstate Brief Battery (CBB) and Brief International Cognition Assessment for MS (BICAMS), were administered at baseline and follow-up. The primary outcome was the change in CBB composite z-score compared between groups. Change in BICAMS composite z-score was also compared, as were change in z-scores of individual measures. Reliable change indices (RCIs) were calculated to determine meaningful change over time. RESULTS: A total of 63/72 (87.5%) of participants with pediatric MS, 81/99 (81.8%) of pediatric controls, and 48/66 (72.7%) of adults with MS returned for follow-up a mean 2.15 ± 0.27 years later. Participants with pediatric MS were median 17.4 years [IQR 16.0-18.3] at time of follow-up with median disease duration of 3.9 years [IQR 2.8-5.6]. 71% were female. There were no significant differences in change in CBB composite z-scores among pediatric MS and pediatric HC groups (0.10 vs 0.31, p = 0.113) or between the pediatric and adult MS groups (0.10 vs 0.00, p = 0.987). Although on RCI of the CBB, 80% of participants with pediatric MS were either stable or improved, more of the pediatric MS group declined relative to the control group 19.7% vs 5.1%, p = 0.022. DISCUSSION: Most individuals with pediatric MS early in their disease showed stable cognitive function over a 2-year period and had longitudinal changes that were largely similar to pediatric controls. A subset of participants with pediatric MS declined in cognitive processing speed relative to pediatric controls.
引用
- O'Neill KA, Charvet L, Waltz M, et al. Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years. Neurology. 2025. PMID: 40966491. doi:10.1212/WNL.0000000000214142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。